Pfizer (PFE)
Latest
-
J&J’s Corporate Split: Just Another Big, Blue-Chip Breakup
Investing for Income Johnson & Johnson is the latest in a line of mega-cap household names that have split their businesses in a bid to boost growth.
By Dan Burrows Published
Investing for Income -
Stock Market Today (11/5/21): Boffo Jobs Report Spurs Fresh Dow Highs
Stock Market Today Investors cheered better-than-expected October payroll gains and a possible breakthrough COVID-19 treatment by vaccine leader Pfizer.
By Kyle Woodley Published
Stock Market Today -
Stock Market Today (11/2/21): Dow 36,000 at Last!
Stock Market Today The Dow closed above the 36,000 level for the first time ever Tuesday, while earnings also pushed the S&P 500 and Nasdaq to new heights.
By Kyle Woodley Published
Stock Market Today -
Analysts Expect Pfizer (PFE) to Deliver a Blowout Q3
stocks Our preview of the upcoming week's earnings reports includes Pfizer (PFE), Square (SQ) and Moderna (MRNA).
By Karee Venema Published
stocks -
9 Big Pharmaceutical Stocks Sporting Stellar Yields
healthcare stocks Large-cap pharmaceutical stocks offer investors stable, substantial dividends, regardless of market conditions. Here are nine that stand out.
By Jeff Reeves Published
healthcare stocks -
Stock Market Today (9/20/21): China's Evergrande Crisis Knocks 614 Points Off Dow
Stock Market Today A possible debt default for a Chinese real estate giant sent shockwaves across global markets and put a dent in U.S. stocks Monday.
By Kyle Woodley Published
Stock Market Today -
6 Beautifully Boring Dividend Stocks
dividend stocks Instead of popular but volatile stocks, owning under-the-radar defensive gems will let you sleep at night.
By Adam Shell Published
dividend stocks -
Stock Market Today (8/24/21): S&P 500, Nasdaq Continue to Carve Out New Highs
Stock Market Today Cyclical and reopening plays helped boost the broader markets.
By Karee Venema Published
Stock Market Today -
Stock Market Today (8/23/21): S&P 500, Nasdaq Hit Record Highs on Pfizer Vaccine Approval
Stock Market Today The Pfizer-BioNTech COVID-19 vaccine became the first to earn full FDA approval Monday, igniting a broad rally in stocks.
By Kyle Woodley Published
Stock Market Today